More Than Just Risk: Genetic Testing Is Shaping Breast Cancer Treatment

https://investor.myriad.com/news-releases/news-release-detail/20971/

Myriad Submits sPMA for BRACAnalysis® CDx as a Companion ...

Jan 21, 2020 ... ... BRCA1/2 or ATM who were treated with olaparib. The trial also met a key secondary endpoint demonstrating significant rPFS with olaparib in ...

https://investor.myriad.com/news-releases/news-release-detail/11311/

Study Reveals High Prevalence of BRCA Mutations in Women With ...

Oct 4, 2010 ... BRACAnalysis is an analysis of the BRCA1 and BRCA2 genes developed by Myriad Genetics for assessing a woman's risk for hereditary breast and ...

https://investor.myriad.com/news-releases/news-release-detail/12101/

Myriad myRisk® Hereditary Cancer Test Demonstrates the ...

Jun 6, 2016 ... ... BRCA1/2 testing alone. However, in these studies we sought to understand the magnitude of risk across 25 genes," said Johnathan Lancaster ...

https://investor.myriad.com/news-releases/news-release-detail/10986/

Myriad myRisk™ Hereditary Cancer Test Is Highly Accurate in Key ...

Oct 24, 2013 ... ... BRCA1 and BRCA2 Genes. [Roa et al., Poster: Oct. 24, 2013 , 11:30 a.m. — 12:30 p.m. ET ]. This study validated the myRisk Hereditary Cancer ...

https://myriad.com/healthcare-professionals/disease.../breast-cancer/

Hereditary Breast Cancer - Myriad Genetics

Myriad offers genetic testing that can be used to identify patients who are carriers of a BRCA1, BRCA2 or other gene mutation.

https://investor.myriad.com/news-releases/news-release-detail/11071/

Myriad and Cephalon Enter Into Companion Diagnostic Agreement

Mar 28, 2012 ... ... BRCA1 and BRCA2 mutation testing ... BRACAnalysis is a molecular diagnostic product developed by Myriad Genetics which analyzes the BRCA1 ...

https://investor.myriad.com/news-releases/news-release-detail/11676/

Myriad Establishes Tumor BRACAnalysis CDx(TM) Laboratory in ...

Oct 24, 2014 ... It is estimated that more than 22 percent of all ovarian cancer patients carry a deleterious germline or somatic mutation in the BRCA1 or BRCA2 ...

https://investor.myriad.com/news-releases/news-release-detail/11751/

Myriad Obtains CE Mark for Tumor BRACAnalysis CDx(TM) and ...

Jan 8, 2015 ... ... BRCA1 or BRCA2 genes. Tumor BRACAnalysis CDx is the first and only tumor-based companion diagnostic that is CE-marked and can identify ...

https://investor.myriad.com/news-releases/news-release-detail/20541/

Myriad Will Seek FDA Approval of BRACAnalysis CDx® As a ...

... BRCA1/2 or ATM gene mutations, a subpopulation of homologous recombination repair gene mutations, lived for longer time without disease progression when ...

https://myriad.com/urology/metastatic-prostate-cancer-patient/

Metastatic Prostate Cancer - Patient Guide | Myriad Urology

What is BRCA1? Both men and women have BRCA genes. Normally, the proteins produced by the BRCA1 and BRCA2 genes prevent cells from developing into cancer.